Albuquerque MLL, Monteiro D, Marinho DA, Vilarino GT, Andrade A,Neiva HP
Current Evidence on GLP-1 Medicines and Cancer Risk Thyroid Cancer Concerns: What the Research Shows Pancreatic and Other Cancer Types: Safety Data UK Regulatory Position on GLP-1 Medicines and Cancer When to Discuss Cancer Risk with Your Healthcare Provider Scientific References Frequently Asked Questions What Are GLP-1 Medicines and How Do They Work
For musculoskeletal use, it is commonly considered for tendon irritation, ligament sprains, muscle strains, fascia-related pain, overuse injuries, and joint-adjacent soft-tissue pain
Once a medication is started we schedule follow-up appointments approximately every 5 weeks and lab work will be repeated on an individual basis
These dosing conditions have been used in the oral semaglutide phase 3 trials and are part of the approved label
No, the effects on insulin sensitivity are generally not permanent and are tied to the presence of elevated GH